Aquestive Therapeutics a new overweight at Piper on oral film products [Seeking Alpha]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Seeking Alpha
The firm has a $10 price target (~146% upside based on Wednesday's close). In the pipeline, Piper's David Absellem likes Anaphylm, an oral film of epinephrine, the long-standing drug used to treat anaphylaxis. He sees a likely U.S. FDA approval in the second half of 2025. "With peak sales potential of roughly $300M-$400M, in the context of a relatively lean commercial model (i.e., high operating margins over time), the risk/reward profile associated with AQST shares is attractive in the context of an EV of ~$345M," Absellem wrote. He added that the allergic response space is ripe for significant expansion given the nearly 32M Americans at risk for severe allergic reactions and injectables only accounting for 4.1M retail prescriptions in 2023, per IQVIA data. "With a market backdrop that reflects a limited generics presence, along with the nature of a rescue therapy in an emergent context with a large pediatric population, we envision a relatively benign payer landscape for Anap
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Clinical Trial Analytics Services Market Projected to Reach $11.95 billion by 2030 - Exclusive Report by 360iResearch [Yahoo! Finance]Yahoo! Finance
- IQVIA (IQV) to Report Q1 Earnings: What's in the Offing? [Yahoo! Finance]Yahoo! Finance
- Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market [Yahoo! Finance]Yahoo! Finance
- How AI-Driven Diagnostics Can Save Lives When Humans Can't [Forbes]Forbes
- Contract Research Organization Services Market Projected to Reach $184.21 billion by 2030 - Exclusive Report by 360iResearch [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 2/14/24 - Beat
IQV
Sec Filings
- 4/17/24 - Form 8-K
- 3/4/24 - Form 4
- 3/4/24 - Form 4
- IQV's page on the SEC website